The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Mesenchymal Stromal Cells Promote Tumor Growth through the Enhancement of Neovascularization
Open accessAbstract
Mesenchymal stromal cells (MSCs), also called mesenchymal stem cells, migrate and function as stromal cells in tumor tissues. The effects of MSCs on tumor growth are controversial. In this study, we showed that MSCs increase proliferation of tumor cells in vitro and promote tumor growth in vivo. We also further analyzed the mechanisms that underlie these effects. For use in in vitro and in vivo experiments, we established a bone marrow-derived mesenchymal stromal cell line from cells isolated in C57BL/6 mice. Effects of murine MSCs on tumor cell proliferation in vitro were analyzed in a coculture model with B16-LacZ cells. Both coculture with MSCs and treatment with MSC-conditioned media led to enhanced growth of B16-LacZ cells, although the magnitude of growth stimulation in cocultured cells was greater than that of cells treated with conditioned media. Co-injection of B16-LacZ cells and MSCs into syngeneic mice led to increased tumor size compared with injection of B16-LacZ cells alone. Identical experiments using Lewis lung carcinoma (LLC) cells instead of B16-LacZ cells yielded similar results. Consistent with a role for neovascularization in MSC-mediated tumor growth, tumor vessel area was greater in tumors resulting from co-injection of B16-LacZ cells or LLCs with MSCs than in tumors induced by injection of cancer cells alone. Co-injected MSCs directly supported the tumor vasculature by localizing close to vascular walls and by expressing an endothelial marker. Furthermore, secretion of leukemia inhibitory factor, macrophage colony-stimulating factor, macrophage inflammatory protein-2 and vascular endothelial growth factor was increased in cocultures of MSCs and B16-LacZ cells compared with B16-LacZ cells alone. Together, these results indicate that MSCs promote tumor growth both in vitro and in vivo and suggest that tumor promotion in vivo may be attributable in part to enhanced angiogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, newer studies have depicted that injection of MSC subcutaneously develops tumor growth and neovascularization in syngeneic mouse models by promoting tumor vasculature and secreting proangiogenic factors [110].”
From Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword (2025) · cites this paper as [110]
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“INTRODUCTION Growth of solid tumors requires formation of the tumor stroma, which supplies oxygen and nutrients to tumor cells (1).”
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
Ortiz, L. A., Gambelli, F., McBride, C., Gaupp, D., Baddoo, M., Kaminski, N., & Phinney, D. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432929100 · Cited by 1,462
Mesenchymal Stem Cell Homing: The Devil Is in the Details
Karp, J. M., & Leng Teo, G. S. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.02.001 · Cited by 1,445
Campagnoli, C., Roberts, I. A. G., Kumar, S., Bennett, P. R., Bellantuono, I., & Fisk, N. M. (2001) · Blood · doi:10.1182/blood.v98.8.2396 · Cited by 1,347
Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals
Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noël, D., & Jorgensen, C. (2003) · Blood · doi:10.1182/blood-2003-04-1193 · Cited by 1,166
Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor Progression
Hwang, R. F., Moore, T. T., Arumugam, T., Ramachandran, V., Amos, K. D., Rivera, A. M., Ji, B., Evans, D. B., & Logsdon, C. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5714 · Cited by 1,117
Cited by
Sorted by citations
Progression and metastasis of lung cancer
Popper, H. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9618-0 · Cited by 551
The Pros and Cons of Mesenchymal Stem Cell-Based Therapies
Musiał-Wysocka, A., Kot, M., & Majka, M. (2019) · Cell Transplantation · doi:10.1177/0963689719837897 · Cited by 553
Mesenchymal stem cells: key players in cancer progression
Ridge, S. M., Sullivan, F. J., & Glynn, S. A. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0597-8 · Cited by 526
Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells
Leibacher, J., & Henschler, R. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0271-2 · Cited by 368
Bronckaers, A., Hilkens, P., Martens, W., Gervois, P., Ratajczak, J., Struys, T., & Lambrichts, I. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.013 · Cited by 359
Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy
Tan, L., Xia, M., Gao, Y., Chen, Y., & Xu, Y. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1051528 · Cited by 259
The roles of mesenchymal stem cells in tumor inflammatory microenvironment
Sun, Z., Wang, S., & Zhao, R. C. (2014) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-7-14 · Cited by 249
Ho, I. A. W., Toh, H. C., Ng, W. H., Teo, Y. L., Guo, C. M., Hui, K. M., & Lam, P. Y. P. (2012) · Stem Cells · doi:10.1002/stem.1247 · Cited by 241
Barcellos‐de‐Souza, P., Comito, G., Segura, C. P., Taddei, M. L., Gori, V., Becherucci, V., Bambi, F., Margheri, F., Laurenzana, A., Rosso, M. D., et al. (2016) · Stem Cells · doi:10.1002/stem.2412 · Cited by 236
Mesenchymal Stem Cells for Chronic Wound Healing: Current Status of Preclinical and Clinical Studies
Huang, Y., Gou, M., Da, L., Zhang, W., & Xie, H. (2020) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2019.0351 · Cited by 213
Double‐edged sword of mesenchymal stem cells: Cancer‐promoting versus therapeutic potential
Lee, H., & Hong, I. (2017) · Cancer Science · doi:10.1111/cas.13334 · Cited by 211
Mesenchymal stem cells in tumor development
Cuiffo, B., & Karnoub, A. E. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20875 · Cited by 213
Tumor microenvironment: Bone marrow-mesenchymal stem cells as key players
Barcellos‐de‐Souza, P., Gori, V., Bambi, F., & Chiarugi, P. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.10.004 · Cited by 187
Cuiffo, B., Campagne, A., Bell, G. W., Lembo, A., Orso, F., Lien, E. C., Bhasin, M., Raimo, M., Hanson, S. E., Marusyk, A., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.10.001 · Cited by 175
Stem Cell Therapy to Cure Type 1 Diabetes: From Hype to Hope
Chhabra, P., & Brayman, K. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0116 · Cited by 157
Hass, R., von der Ohe, J., & Ungefroren, H. (2020) · Cancers · doi:10.3390/cancers12123716 · Cited by 154
Adverse events, side effects and complications in mesenchymal stromal cell-based therapies
Baranovskii, D., Klabukov, I., Arguchinskaya, N. V., Yakimova, A. O., Kisel, A. A., Yatsenko, E. M., Иванов, С. А., Шегай, П. В., & Каприн, А. Д. (2022) · Stem Cell Investigation · doi:10.21037/sci-2022-025 · Cited by 154
Mechanisms of T-Cell Immunosuppression by Mesenchymal Stromal Cells: What Do We Know So Far?
Haddad, R., & Saldanha-Araujo, F. (2014) · BioMed Research International · doi:10.1155/2014/216806 · Cited by 188
Stem cells in the treatment of diabetes mellitus — Focus on mesenchymal stem cells
Päth, G., Perakakis, N., Mantzoros, C. S., & Seufert, J. (2018) · Metabolism · doi:10.1016/j.metabol.2018.10.005 · Cited by 137
Mesenchymal stem cells: From regeneration to cancer
Li, P., Gong, Z., Shultz, L. D., & Ren, G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.005 · Cited by 133
Stem cell exosomes inhibit angiogenesis and tumor growth of oral squamous cell carcinoma
Rosenberger, L., Ezquer, M., Lillo-Vera, F., Pedraza, P. L., Ortúzar, M. I., González, P. L., Figueroa‐Valdés, A. I., Cuenca, J., Ezquer, F. E., Khoury, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-36855-6 · Cited by 138
Mesenchymal Stem Cells in the Tumor Microenvironment
Atiya, H. I., Frisbie, L. G., Pressimone, C. A., & Coffman, L. G. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-37184-5_3 · Cited by 129
Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review
Christodoulou, I., Goulielmaki, M., Devetzi, M., Panagiotidis, M., Koliakos, G., & Zoumpourlis, V. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1078-8 · Cited by 122
Mesenchymal stem cells: The roles and functions in cutaneous wound healing and tumor growth
Motegi, S., & Ishikawa, O. (2016) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2016.11.005 · Cited by 123
Role of MSC in the Tumor Microenvironment
Hass, R. (2020) · Cancers · doi:10.3390/cancers12082107 · Cited by 116
Lee, M. W., Ryu, S., Kim, D. S., Lee, J. W., Sung, K. W., Koo, H. H., & Yoo, K. H. (2019) · Leukemia · doi:10.1038/s41375-018-0373-9 · Cited by 116
Interactions of Mesenchymal Stem Cells with Endothelial Cells
Nassiri, S. M., & Rahbarghazi, R. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0419 · Cited by 113
Advances in pathogenic mechanisms and management of radiation-induced fibrosis
Wang, B., Wei, J., Meng, L., Wang, H., Qu, C., Chen, X., Xin, Y., & Jiang, X. M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109560 · Cited by 100
Mesenchymal stem cells in the tumor microenvironment
GUAN, J., & Chen, J. (2013) · Biomedical Reports · doi:10.3892/br.2013.103 · Cited by 94
Zhao, X., Wu, X., Qian, M., Song, Y., Wu, D. L., & Zhang, W. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.026 · Cited by 94
Camorani, S., Hill, B. S., Fontanella, R., Greco, A., Gramanzini, M., Auletta, L., Gargiulo, S., Albanese, S., Lucarelli, E., Cerchia, L., et al. (2017) · Theranostics · doi:10.7150/thno.18974 · Cited by 92
Mitochondrial oxidative phosphorylation in cutaneous melanoma
Kumar, P. R., Moore, J. A., Bowles, K. M., Rushworth, S. A., & Moncrieff, M. D. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01159-y · Cited by 92
Wang, J., Wang, Y., Wang, S., Cai, J., Shi, J., Sui, X. Y., Cao, Y., Huang, W., Chen, X., Cai, Z., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5739 · Cited by 94
Pietrovito, L., Leo, A., Gori, V., Lulli, M., Parri, M., Becherucci, V., Piccini, L., Bambi, F., Taddei, M. L., & Chiarugi, P. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12189 · Cited by 91
Liu, X., Wu, M., Peng, Y., Chen, X., Sun, J., Huang, F., Fan, Z., Zhou, H., Wu, X., Yu, G., et al. (2013) · Cell Transplantation · doi:10.3727/096368912x661319 · Cited by 88
Current Perspectives in Mesenchymal Stem Cell Therapies for Osteoarthritis
Kristjánsson, B., & Honsawek, S. (2014) · Stem Cells International · doi:10.1155/2014/194318 · Cited by 87
Yamada, K., Uchiyama, A., Uehara, A., Perera, B., Ogino, S., Yokoyama, Y., Takeuchi, Y., Udey, M. C., Ishikawa, O., & Motegi, S. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2812 · Cited by 87
c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia
Xia, B., Tian, C., Guo, S., Zhang, L., Zhao, D., Qu, F., Zhao, W., Wang, Y., Wu, X., Da, W.-M., et al. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.11.004 · Cited by 86
Zhu, W., Wang, M., Fu, Y., Castro, N. J., Fu, S. W., & Zhang, L. G. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.12.008 · Cited by 85
Fontanella, R., Pelagalli, A., Nardelli, A., D'Alterio, C., Ieranò, C., Cerchia, L., Lucarelli, E., Scala, S., & Zannetti, A. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.10.018 · Cited by 79
Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts
Pacioni, S., D’Alessandris, Q. G., Giannetti, S., Morgante, L., Coccè, V., Bonomi, A., Buccarelli, M., Pascucci, L., Alessandri, G., Pessina, A., et al. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0516-3 · Cited by 82
Hughes, R. M., Simons, B. W., Khan, H., Miller, R., Kugler, V., Torquato, S., Theodros, D., Haffner, M. C., Lotan, T. L., Huang, J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2931 · Cited by 77
Shahar, T., Rozovski, U., Hess, K. R., Hossain, A., Gumin, J., Gao, F., Fuller, G. N., Goodman, L. D., Sulman, E. P., & Lang, F. F. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now239 · Cited by 76
Cell Sources for Articular Cartilage Repair Strategies: Shifting from Monocultures to Cocultures
Leijten, J., Georgi, N., Wu, L., van Blitterswijk, C., & Karperien, M. (2012) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2012.0273 · Cited by 75
Fathi, E., Sanaat, Z., & Farahzadi, R. (2019) · Blood Research · doi:10.5045/br.2019.54.3.165 · Cited by 76
Mesenchymal stromal cells as cancer promoters
Antoon, R., Overdevest, N., Saleh, A. H., & Keating, A. (2024) · Oncogene · doi:10.1038/s41388-024-03183-1 · Cited by 75
Kalimuthu, S., Gangadaran, P., Li, X. J., Oh, J. M., Lee, H., Jeong, S. Y., Lee, S., Lee, J., & Ahn, B. (2016) · Scientific Reports · doi:10.1038/srep30418 · Cited by 73
Adipose Tissue Regeneration: A State of the Art
Casadei, A., Epis, R., Ferroni, L., Tocco, I., Gardin, C., Bressan, E. A., Sivolella, S., Vindigni, V., Pinton, P., Mucci, G., et al. (2012) · BioMed Research International · doi:10.1155/2012/462543 · Cited by 73
Mesenchymal stem cells and cancer therapy: insights into targeting the tumour vasculature
Surendar, A., Ejam, S. S., Lafta, M. H., Markov, A. A., Yumashev, A. V., & Ahmadi, M. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01836-9 · Cited by 71
Kansy, B., Dissmann, P. A., Hemeda, H., Bruderek, K., Westerkamp, A. M., Jagalski, V., Schuler, P. J., Kansy, K., Lang, S., Dumitru, C. A., et al. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt484 · Cited by 70
The Role of MSCs in the Tumor Microenvironment and Tumor Progression
Ahn, S. Y. (2020) · Anticancer Research · doi:10.21873/anticanres.14284 · Cited by 70
Levy, D. M., Petersen, K. A., Vaught, M. S., Christian, D. R., & Cole, B. J. (2018) · Arthroscopy The Journal of Arthroscopic and Related Surgery · doi:10.1016/j.arthro.2018.02.022 · Cited by 69
Javan, M., Khosrojerdi, A., & Moazzeni, S. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00840 · Cited by 68
Benton, G., DeGray, G., Kleinman, H. K., George, J., & Arnaoutova, I. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123312 · Cited by 67
Bone Marrow–Derived Mesenchymal Stromal Cells Promote Survival and Drug Resistance in Tumor Cells
Bergfeld, S. A., Blavier, L., & DeClerck, Y. A. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0400 · Cited by 62
Bu, S., Wang, Q., Zhang, Q., Sun, J., He, B., Xiang, C., Liu, Z., & Lai, D. (2016) · Scientific Reports · doi:10.1038/srep37019 · Cited by 63
MSC and Tumors: Homing, Differentiation, and Secretion Influence Therapeutic Potential
D’souza, N., Burns, J. S., Grisendi, G., Candini, O., Veronesi, E., Piccinno, M. S., Horwitz, E. M., Paolucci, P., Conte, P., & Dominici, M. (2012) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2012_150 · Cited by 63
Lymphatic endothelial cells support tumor growth in breast cancer
Lee, E., Pandey, N. B., & Popel, A. S. (2014) · Scientific Reports · doi:10.1038/srep05853 · Cited by 62
Pleyer, L., Valent, P., & Greil, R. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071009 · Cited by 63
Mesenchymal stem cells confer chemoresistance in breast cancer via a CD9 dependent mechanism
Ullah, M., Akbar, A., Ng, N. N., Concepcion, W., & Thakor, A. S. (2019) · Oncotarget · doi:10.18632/oncotarget.26952 · Cited by 60
Slama, Y., Ah-Pine, F., Khettab, M., Arcambal, A., Begue, M., Dutheil, F., & Gasque, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713511 · Cited by 57
Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway
Atsuta, I., Liu, S., Miura, Y., Akiyama, K., Chen, C., An, Y., Shi, S., & Chen, F.-M. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt322 · Cited by 57
IL-17 Signaling in the Tumor Microenvironment
Gorczynski, R. M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38315-2_4 · Cited by 57
The dual effect of mesenchymal stem cells on tumour growth and tumour angiogenesis
Kéramidas, M., de Fraipont, F., Karageorgis, A., Moisan, A., Persoons, V., Richard, M., Coll, J., & Rome, C. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt195 · Cited by 53
Development and Prospect of Intra-Articular Injection in the Treatment of Osteoarthritis: A Review
Zhang, Y., Chen, X.-J., Tong, Y., Luo, J., & Bi, Q. (2020) · Journal of Pain Research · doi:10.2147/jpr.s260878 · Cited by 41
Romano, B., Elangovan, S., Erreni, M., Sala, E., Petti, L., Kunderfranco, P., Massimino, L., Restelli, S., Sinha, S., Lucchetti, D., et al. (2019) · Stem Cells · doi:10.1002/stem.3010 · Cited by 50
Liu, R., Wei, S., Chen, J., & Xu, S. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.07.047 · Cited by 50
Xu, Y., Tokar, E. J., Sun, Y., & Waalkes, M. P. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1204987 · Cited by 49
Recent progress in the research of suicide gene therapy for malignant glioma
Tamura, R., Miyoshi, H., Yoshida, K., Okano, H., & Toda, M. (2019) · Neurosurgical Review · doi:10.1007/s10143-019-01203-3 · Cited by 50
Chen, D., Tang, P., Liu, L., Wang, F., Xing, H., Sun, L., & Jiang, Z. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1442624 · Cited by 48
Gyukity-Sebestyén, E., Harmati, M., Dobra, G., Németh, I. B., Mihály, J., Zvara, Á., Hunyadi‐Gulyás, É., Katona, R. L., Nagy, I., Horváth, P., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02459 · Cited by 47
Endoglin in the Spotlight to Treat Cancer
González-Muñoz, T., Amaral, A. T., Puerto‐Camacho, P., Peinado, H., & de Álava, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063186 · Cited by 47
Mesenchymal Stromal Cells: Emerging Roles in Bone Metastasis
Graham, N., & Qian, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041121 · Cited by 45
Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour
Fakiruddin, K. S., Ghazalli, N., Lim, M. N., Zakaria, Z., & Abdullah, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082188 · Cited by 46
Fate of Intravenously Injected Mesenchymal Stem Cells and Significance for Clinical Application
Wagner, B., & Henschler, R. (2012) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2012_155 · Cited by 45
Zeng, J., Chen, S., Li, C., Ye, Z., Lin, B., Liang, Y., Wang, B., Ma, Y., Chai, X., Zhang, X., et al. (2020) · Journal of Cancer · doi:10.7150/jca.37932 · Cited by 44
Lee, W., Zhang, T., Lau, C., Wang, C. C., Chan, K., & Li, G. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.06.010 · Cited by 44
Human mesenchymal stem cells in the treatment of neurological diseases
Drela, K., Siedlecka, P., Sarnowska, A., & Domańska‐Janik, K. (2013) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2013-1920 · Cited by 43
Gamie, Z., Kapriniotis, K., Papanikolaou, D., Haagensen, E., Da Conceicao Ribeiro, R., Dalgarno, K., Krippner-Heidenreich, A., Gerrand, C., Tsiridis, E., & Rankin, K. S. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.08.036 · Cited by 44
Riedl, J., Popp, C. M., Eide, C. R., Ebens, C. L., & Tolar, J. (2021) · Cytotherapy · doi:10.1016/j.jcyt.2021.06.004 · Cited by 51
Kar, S., Molla, M. S., Katti, D. R., & Katti, K. S. (2018) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2773 · Cited by 43
Classification and biology of tumour associated stromal cells
Raffaghello, L., & Dazzi, F. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.06.016 · Cited by 47
Mesenchymal stem cells in the colorectal tumor microenvironment: Recent progress and implications
Hogan, N. M., Dwyer, R. M., Joyce, M., & Kerin, M. J. (2012) · International Journal of Cancer · doi:10.1002/ijc.27458 · Cited by 42
Park, S.-J., Kim, K., Kim, W., & Cho, C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302177 · Cited by 42
Ba, L., Xue, C., Li, X., Zhang, M., Yang, Y., Han, Q., Sun, Z., & Zhao, R. C. (2021) · Stem Cells and Development · doi:10.1089/scd.2021.0059 · Cited by 40
Mesenchymal/stromal stem cells: necessary factors in tumour progression
Li, X., Fan, Q., Peng, X., Yang, S., Wei, S., Liu, J., Yang, L., & Li, H. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01107-0 · Cited by 42
Mesenchymal stem cells promote glioma neovascularization in vivo by fusing with cancer stem cells
Sun, C., Dai, X., Zhao, D., Wang, H., Rong, X., Huang, Q., & Lan, Q. (2019) · BMC Cancer · doi:10.1186/s12885-019-6460-0 · Cited by 39
Jiang, Y., Chao, C., Chang, A., Chen, P., Cheng, F., Liu, J., Liu, P., Huang, C., Guo, J., Huang, W., et al. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.12.011 · Cited by 38
Messina, V., Valtieri, M., Rubio, M., Falchi, M., Mancini, F., Mayor, A. G., Alano, P., & Silvestrini, F. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00050 · Cited by 37
Freeman, F. E., Burdis, R., Mahon, O. R., Kelly, D. J., & Artzi, N. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101296 · Cited by 36
Mesenchymal Stem Cells as Endogenous Regulators of Inflammation
Munir, H., Ward, L. S. C., & McGettrick, H. M. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-78127-3_5 · Cited by 42
Genetically-modified Stem Cell in Regenerative Medicine and Cancer Therapy; A New Era
Verdi, J., Hassanzadeh, A., Shamlou, S., Yousefi, N., & Nikoo, M. (2021) · Current Gene Therapy · doi:10.2174/1566523221666210707125342 · Cited by 36
Lim, S. K., & Khoo, B. Y. (2021) · Oncology Letters · doi:10.3892/ol.2021.13046 · Cited by 40
Zoledronic acid in breast cancer: latest findings and interpretations
Gnant, M. (2011) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834011420599 · Cited by 34
Ridge, S. M., Bhattacharyya, D. D., Dervan, E., Naicker, S. D., Burke, A. J., Murphy, M. J., O’Leary, K., Greene, J. P., Ryan, A. E., Sullivan, F. J., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.31226 · Cited by 35
Jazowiecka-Rakus, J., Sochanik, A., Rusin, A., Hadryś, A., Fidyk, W., Villa, N., Rahman, M. M., Chmielik, E., Franco, L. S., & McFadden, G. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.07.003 · Cited by 33
Eiró, N., Fraile, M., Fernández-Francos, S., Sánchez, R., Costa, L. A., & Vizoso, F. J. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00620-6 · Cited by 33
Szebeni, G. J., Kriston-Pál, É., Blazsó, P., Katona, R. L., Novák, J., Szabó, E. V., Czibula, Á., Fajka‐Boja, R., Hegyi, B., Uher, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041372 · Cited by 33
Vulcano, F., Milazzo, L., Ciccarelli, C., Eramo, A., Sette, G., Mauro, A., Macioce, G., Martinelli, A., Torre, R. L., Casalbore, P., et al. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.06.003 · Cited by 32
Moloudizargari, M., Govahi, A., Fallah, M., Rezvanfar, M. A., Asghari, M. H., & Abdollahi, M. R. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30038 · Cited by 32
Metadata
- Authors
- Suzuki, K., Sun, R., Origuchi, M., Kanehira, M., Takahata, T., Itoh, J., Umezawa, A., Kijima, H., Fukuda, S., & Saijo, Y.
- Affiliations
- Hirosaki University (JP)
- Tohoku University (JP)
- National Center For Child Health and Development (JP)
- Corresponding author
- Saijo, Yasuo
- Venue
- Molecular Medicine
- Published
- 2011-03-11
- Volume
- 17
- Issue
- 7-8
- Pages
- 579-587
- ISSN
- 1076-1551 (ISSN-L)
- 1528-3658
- PMC
- PMC3146617
- OpenAlex
- W2207758069
- Cited by
- 244
- References
- 38
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 11 · 2023: 10 · 2022: 12 · 2021: 17 · 2020: 24 · 2019: 19 · 2018: 25 · 2017: 14 · 2016: 25 · 2015: 16 · 2014: 21 · 2013: 12 · 2012: 17
- FWCI
- 8.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Molecular Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (16022206, 20390229, 23790895, 22659160)
- RIKEN
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- mesenchymal stem cells, tumor growth, tumor angiogenesis, angiogenesis, tumor cell proliferation, bone marrow-derived stromal cells, Lewis lung carcinoma, leukemia inhibitory factor, macrophage colony-stimulating factor, CXCL2, vascular endothelial growth factor, tumor vasculature
- MeSH terms
- Animals, Cells, Cultured, Female, Flow Cytometry, Mice, Transgenic, Neoplasm Transplantation, Neoplasms, Experimental, Neovascularization, Pathologic, Macrophage Colony-Stimulating Factor, Microscopy, Confocal, Coculture Techniques, Antigens, CD34, Vascular Endothelial Growth Factor A, Mesenchymal Stem Cell Transplantation, Cell Line, Tumor, Tumor Burden, Cell Proliferation, Green Fluorescent Proteins, Mice, Chemokine CXCL2, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review